{
  "docId": "019f6b8e-fcff-749d-9e42-455320e9fd38",
  "docSlug": "jarvis-beckley-psytech-pitch-deck",
  "documentTitle": "Beckley Psytech Pitch Deck",
  "authorId": "beckley-psytech-pitch-deck",
  "authorName": null,
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": null,
  "orientation": null,
  "aspectRatio": null,
  "pageNumber": 13,
  "pageCount": 22,
  "prevPage": 12,
  "nextPage": 14,
  "slideType": "solution",
  "function": "present_solution",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a maturity model or generational framework to categorize R&D efforts.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019f6b8e-fcff-749d-9e42-455320e9fd38/13",
  "deckHref": "/decks/019f6b8e-fcff-749d-9e42-455320e9fd38",
  "deckJsonHref": "/decks/019f6b8e-fcff-749d-9e42-455320e9fd38.json",
  "deckAnchorHref": "/decks/019f6b8e-fcff-749d-9e42-455320e9fd38#slide-13",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.9,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "framework",
      "text": "1st Generation Program: Progressing innovative formulations and novel applications of well-characterized psychedelic agents.",
      "attrs": null,
      "subkind": "instance",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3a96123e-fdcc-4df4-8005-f978dc1a8797",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.9,
        "x": 0.05,
        "y": 0.45
      },
      "kind": "framework",
      "text": "2nd Generation Program: Develop known but under-researched psychedelic agents offering stronger IP, clinical, and patient access advantages.",
      "attrs": null,
      "subkind": "instance",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "843c82c9-1384-4e02-b89e-f5d7e177e26a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.9,
        "x": 0.05,
        "y": 0.65
      },
      "kind": "framework",
      "text": "3rd Generation Program: Design New Chemical Entities (NCEs) that improve upon existing psychedelics by providing better patient and health economic outcomes.",
      "attrs": null,
      "subkind": "instance",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8f10413c-9de6-46f4-a58a-e714cd541de1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Drug Development Platform: Building a portfolio of psychedelic assets to manage risk and maximise commercial potential",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6975ebe3-7806-4080-8cee-90a29755863c",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Three Pillars",
      "slug": "three-pillars",
      "agent": "Architect",
      "layer": "slide",
      "matchId": "38a09f0d-3eda-4620-bbf1-eaec1b876e75",
      "evidence": "framework/instance: 3rd Generation Program, 2nd Generation Program, 1st Generation Program",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "maturity-model",
      "slug": null,
      "matchId": "733599f1-3829-41cf-b178-ca935c3bd70e",
      "evidence": "Categorization of programs into 1st, 2nd, and 3rd generations based on innovation and development stage.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 16,
      "from": 13,
      "beatId": "bdaf3e00-dfb7-4bb9-9086-70c5b90ccdfa",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Solution",
      "beatSlug": "sequoia-pitch-solution",
      "evidence": "The solution is presented on pages 13-16, with a focus on the drug development platform and team",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}